Drug Delivery Into the Tumor Vasculature With the Cell-Internalizing Monoclonal Antibody

Drug Delivery System - Japan
doi 10.2745/dds.28.430
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Society of Drug Delivery System

Related search

Drug Delivery: Into the Tumour

Nature
Multidisciplinary
2009English

Hollow Mesoporous Silica Nanoparticles for Tumor Vasculature Targeting and PET Image-Guided Drug Delivery

Nanomedicine
DevelopmentMaterials ScienceNanoscienceMedicineBioengineeringNanotechnologyBiomedical Engineering
2015English

Tumor-Targeted Drug Delivery With Aptamers

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2011English

Antibody–drug Conjugates: Using Monoclonal Antibodies for Delivery of Cytotoxic Payloads to Cancer Cells

Therapeutic Delivery
Pharmaceutical Science
2011English

Long-Term Delivery of an Anti-Siv Monoclonal Antibody With AAV

Frontiers in Immunology
AllergyImmunology
2020English

A Tumor-Selective Monoclonal Antibody From Immunization With a Tumor-Associated Mucin Glycopeptide

Scientific Reports
Multidisciplinary
2019English

Radiation-Induced Galectin-1 by Endothelial Cells: A Promising Molecular Target for Preferential Drug Delivery to the Tumor Vasculature

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2012English

A Cell-Killing Monoclonal Antibody (Anti-Fas) to a Cell Surface Antigen Co-Downregulated With the Receptor of Tumor Necrosis Factor

Journal of Experimental Medicine
MedicineAllergyImmunology
1989English

A Monoclonal Antibody Detecting Cell Surface Epitope on Some Drug Resistant Human Tumour Cell Lines

British Journal of Cancer
Cancer ResearchOncology
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy